Optigenex OPGX · USD

Its shares trade under the ticker OPGX. It has been listed since 15 April 2005. In the fiscal year to 31 December 2010, it reported revenue of $991,250 and a net loss of $685,132. At that date it held total assets of $1.9m and shareholders' equity of −$3.7m.

Optigenex, Inc. is engaged in the manufacturing and licensing of beauty, dietary supplements and personal care products. The company is headquartered in Melissa, Texas. The company went IPO on 2005-04-15. The firm is focused on healthy age management. The firm is a provider of dietary supplements, skin care products and bulk ingredients. The firm formulates, licenses and markets its own natural cellular deoxyribonucleic acid (DNA) care ingredient known as AC-11. The AC-11 is a bioactive and water-soluble rainforest ingredient derived from the medicinal herb Uncaria tomentosa. The firm's customers include manufacturers, distributors and retailers across the world in the dietary supplement and anti-aging topical skin care, cosmetic and cosmeceutical market categories. The firm's product, AC-11, enhances the natural DNA repair processes. AC-11 is sold for ingestible use and topical application. In topical applications, it is known under the brand name AC-11. AC-11 is listed under its International Nomenclature of Cosmetics Ingredients (INCI) names Maltodextrin and C1-8 Alkyl Tetrahydroxycyclohexanoate.

Figures and description from our data supplier, not checked against the company's own report.

More about Optigenex →

We have not reported on Optigenex yet.

Leaves out fees, taxes and financing.

Chart

TradingView

Close and company data

Our data supplier

News

Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.